271 related articles for article (PubMed ID: 16566047)
1. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.
Budde M; Morr M; Schmid RD; Urlacher VB
Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047
[TBL] [Abstract][Full Text] [Related]
2. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
3. Are branched chain fatty acids the natural substrates for P450(BM3)?
Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
[TBL] [Abstract][Full Text] [Related]
4. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
5. Construction of a thermostable cytochrome P450 chimera derived from self-sufficient mesophilic parents.
Eiben S; Bartelmäs H; Urlacher VB
Appl Microbiol Biotechnol; 2007 Jul; 75(5):1055-61. PubMed ID: 17468867
[TBL] [Abstract][Full Text] [Related]
6. Bacillus megaterium CYP102A1 oxidation of acyl homoserine lactones and acyl homoserines.
Chowdhary PK; Keshavan N; Nguyen HQ; Peterson JA; González JE; Haines DC
Biochemistry; 2007 Dec; 46(50):14429-37. PubMed ID: 18020460
[TBL] [Abstract][Full Text] [Related]
7. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
[TBL] [Abstract][Full Text] [Related]
8. Altering the regioselectivity of cytochrome P450 CYP102A3 of Bacillus subtilis by using a new versatile assay system.
Lentz O; Feenstra A; Habicher T; Hauer B; Schmid RD; Urlacher VB
Chembiochem; 2006 Feb; 7(2):345-50. PubMed ID: 16381045
[TBL] [Abstract][Full Text] [Related]
9. Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options.
Whitehouse CJ; Bell SG; Tufton HG; Kenny RJ; Ogilvie LC; Wong LL
Chem Commun (Camb); 2008 Feb; (8):966-8. PubMed ID: 18283351
[TBL] [Abstract][Full Text] [Related]
10. The role of the conserved threonine in P450 BM3 oxygen activation: substrate-determined hydroxylation activity of the Thr268Ala mutant.
Cryle MJ; De Voss JJ
Chembiochem; 2008 Jan; 9(2):261-6. PubMed ID: 18161730
[TBL] [Abstract][Full Text] [Related]
11. A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A.
Schwaneberg U; Schmidt-Dannert C; Schmitt J; Schmid RD
Anal Biochem; 1999 May; 269(2):359-66. PubMed ID: 10222011
[TBL] [Abstract][Full Text] [Related]
12. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
13. Cloning, expression and characterisation of CYP102A2, a self-sufficient P450 monooxygenase from Bacillus subtilis.
Budde M; Maurer SC; Schmid RD; Urlacher VB
Appl Microbiol Biotechnol; 2004 Dec; 66(2):180-6. PubMed ID: 15375636
[TBL] [Abstract][Full Text] [Related]
14. Roles of key active-site residues in flavocytochrome P450 BM3.
Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
[TBL] [Abstract][Full Text] [Related]
15. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of native and mutated cytochrome P450 (CYP102A3) from Bacillus subtilis.
Lentz O; Urlacher V; Schmid RD
J Biotechnol; 2004 Feb; 108(1):41-9. PubMed ID: 14741768
[TBL] [Abstract][Full Text] [Related]
17. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
[TBL] [Abstract][Full Text] [Related]
18. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
Peters MW; Meinhold P; Glieder A; Arnold FH
J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
[TBL] [Abstract][Full Text] [Related]
19. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
Urlacher VB; Schmid RD
Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
[No Abstract] [Full Text] [Related]
20. Combining substrate dynamics, binding statistics, and energy barriers to rationalize regioselective hydroxylation of octane and lauric acid by CYP102A1 and mutants.
Feenstra KA; Starikov EB; Urlacher VB; Commandeur JN; Vermeulen NP
Protein Sci; 2007 Mar; 16(3):420-31. PubMed ID: 17322527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
